DrugPatentWatch Database Preview
Drugs in MeSH Category Cardiovascular Agents
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 210054-002 | May 28, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Glenmark Generics | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 091276-002 | Dec 22, 2010 | AB | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Cadila | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 090403-001 | Nov 15, 2010 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sunshine Lake | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211865-001 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
